Injective (INJ) Price Breaking Out Again: Here's How High It Could Spike

INJ has already surged by around 40% in the past four weeks, and based on the latest chart action, it looks like the rally may only be getting started.

Injective (INJ) price is showing signs of a breakout that could spark a strong rally, according to a recent analysis.

If the bullish thesis plays out, it could see INJ price surging at least 82% from current levels.

What Is Happening Injective (INJ) Price Chart

According to cryptocurrency analyst, the chart shows Injective trading inside a clear descending channel since late 2024.

This type of setup is often an indication of a controlled trend, where traders can capitalize on each bounce and the breakout, when it arrives, is swift and strong.

The chart shows the INJ price now breaking above the upper boundary of the descending channel on the daily chart. This move is coming after months of sustained selling pressure.

This breakout is also setting up the possibility of Injective closing above that key resistance level for the first time in four months, which adds to the significance of this move.

It is also putting the crypto in a position to quickly rally to the next resistance, which comes at around $14.0 to $15.0. A move of this magnitude could come rapidly if the breakout sparks a wave of demand.

Where Is INJ Price Headed Next?

The green target zone suggests that the INJ price could climb toward $18. That would represent an impressive 82% gain from the breakout area.

It’s not just a random number. That level matches up with an earlier resistance zone from early 2025, giving it added technical relevance.

Breakouts like this often ignite interest from new buyers who were waiting for confirmation that the trend has changed. If volume continues to build and Injective stays above the old channel resistance, this could be the start of a much larger rally.

This setup is one that experienced traders tend to take seriously, and it could have some traders setting their sights even higher.